Pirfenidone: In Idiopathic Pulmonary Fibrosis

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.13, 2011-09, pp. : 1721-1732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pirfenidone: a guide to its use in idiopathic pulmonary fibrosis

By Keating Gillian M. Lyseng-Williamson Katherine A. Carter Natalie J.

Drugs & Therapy Perspectives, Vol. 28, Iss. 7, 2012-07 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation

By Antoniu Sabina A

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1443-1447

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 4, 2015-05 ,pp. : 205-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recognition and Treatment of Idiopathic Pulmonary Fibrosis

By Nicod L.P.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 555-562

Adis International

Access to resources Recommend Favorite

Emerging drugs for idiopathic pulmonary fibrosis

By Selman Moiséés Pardo Annie Richeldi Luca Cerri Stefania

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 341-362

Informa Healthcare

Access to resources Recommend Favorite